Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Efficacy, Safety, and Durability of Voretigene Neparvovec-rzyl in RPE65 Mutation-Associated Inherited Retinal Dystrophy: Results of Phase 1 and 3 Trials.

Maguire AM, Russell S, Wellman JA, Chung DC, Yu ZF, Tillman A, Wittes J, Pappas J, Elci O, Marshall KA, McCague S, Reichert H, Davis M, Simonelli F, Leroy BP, Wright JF, High KA, Bennett J.

Ophthalmology. 2019 Sep;126(9):1273-1285. doi: 10.1016/j.ophtha.2019.06.017. Epub 2019 Jun 22.

2.

Ultrasound measurements of the caudal vena cava before and after blood donation in 9 greyhound dogs.

Marshall KA, Thomovsky EJ, Brooks AC, Johnson PA, Lim CK, Heng HG.

Can Vet J. 2018 Sep;59(9):973-980.

3.

Prevalence of bacterial contamination in 50% dextrose vials in varying storage conditions after multiple punctures.

Marshall KA, Brooks AC, Hammac GK, Thomovsky EJ, Johnson PA.

J Small Anim Pract. 2018 Dec;59(12):758-762. doi: 10.1111/jsap.12906. Epub 2018 Jul 4.

PMID:
29972244
4.

Nutrition in Older Adults.

Marshall KA, Hale D.

Home Healthc Now. 2018 May/Jun;36(3):192-193. doi: 10.1097/NHH.0000000000000682. No abstract available.

PMID:
29722711
5.

Reminiscence.

Marshall KA, Hale D.

Home Healthc Now. 2018 Mar/Apr;36(2):124-125. doi: 10.1097/NHH.0000000000000659. No abstract available.

PMID:
29498993
6.

Elder Abuse.

Marshall KA, Hale D.

Home Healthc Now. 2018 Jan/Feb;36(1):51-52. doi: 10.1097/NHH.0000000000000648. No abstract available.

PMID:
29298198
7.

Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial.

Russell S, Bennett J, Wellman JA, Chung DC, Yu ZF, Tillman A, Wittes J, Pappas J, Elci O, McCague S, Cross D, Marshall KA, Walshire J, Kehoe TL, Reichert H, Davis M, Raffini L, George LA, Hudson FP, Dingfield L, Zhu X, Haller JA, Sohn EH, Mahajan VB, Pfeifer W, Weckmann M, Johnson C, Gewaily D, Drack A, Stone E, Wachtel K, Simonelli F, Leroy BP, Wright JF, High KA, Maguire AM.

Lancet. 2017 Aug 26;390(10097):849-860. doi: 10.1016/S0140-6736(17)31868-8. Epub 2017 Jul 14. Erratum in: Lancet. 2017 Aug 26;390(10097):848.

8.

The Role of the Human Visual Cortex in Assessment of the Long-Term Durability of Retinal Gene Therapy in Follow-on RPE65 Clinical Trial Patients.

Ashtari M, Nikonova ES, Marshall KA, Young GJ, Aravand P, Pan W, Ying GS, Willett AE, Mahmoudian M, Maguire AM, Bennett J.

Ophthalmology. 2017 Jun;124(6):873-883. doi: 10.1016/j.ophtha.2017.01.029. Epub 2017 Feb 23.

9.

Fluid Therapy-Part II: Introduction.

Marshall KA.

Top Companion Anim Med. 2016 Sep;31(3):85. doi: 10.1053/j.tcam.2016.10.002. No abstract available.

PMID:
27968813
10.

Fluid Therapy: Introduction.

Marshall KA.

Top Companion Anim Med. 2016 Jun;31(2):45. doi: 10.1053/j.tcam.2016.10.001. No abstract available.

PMID:
27968752
11.

Choosing Wisely.

Marshall KA, Hale D.

Home Healthc Now. 2016 Oct;34(9):519-20. doi: 10.1097/NHH.0000000000000450. No abstract available.

PMID:
27677066
12.

Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial.

Bennett J, Wellman J, Marshall KA, McCague S, Ashtari M, DiStefano-Pappas J, Elci OU, Chung DC, Sun J, Wright JF, Cross DR, Aravand P, Cyckowski LL, Bennicelli JL, Mingozzi F, Auricchio A, Pierce EA, Ruggiero J, Leroy BP, Simonelli F, High KA, Maguire AM.

Lancet. 2016 Aug 13;388(10045):661-72. doi: 10.1016/S0140-6736(16)30371-3. Epub 2016 Jun 30.

13.

Hospital Admissions for Malnutrition and Dehydration in Patients With Dementia.

Marshall KA, Burson R, Gall K, Saunders MM.

Home Healthc Now. 2016 Jan;34(1):32-7. doi: 10.1097/NHH.0000000000000327.

PMID:
26645842
14.

Plasticity of the human visual system after retinal gene therapy in patients with Leber's congenital amaurosis.

Ashtari M, Zhang H, Cook PA, Cyckowski LL, Shindler KS, Marshall KA, Aravand P, Vossough A, Gee JC, Maguire AM, Baker CI, Bennett J.

Sci Transl Med. 2015 Jul 15;7(296):296ra110. doi: 10.1126/scitranslmed.aaa8791.

15.

Dementia and the home healthcare clinician.

Marshall KA.

Home Healthc Now. 2015 Mar;33(3):150-4. doi: 10.1097/NHH.0000000000000210. Review.

PMID:
25738273
16.

Development and validation of a tool to measure incivility in clinical nursing education.

Anthony M, Yastik J, MacDonald DA, Marshall KA.

J Prof Nurs. 2014 Jan-Feb;30(1):48-55. doi: 10.1016/j.profnurs.2012.12.011. Epub 2013 Dec 15.

PMID:
24503315
17.

NCBI GEO: archive for functional genomics data sets--update.

Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH, Sherman PM, Holko M, Yefanov A, Lee H, Zhang N, Robertson CL, Serova N, Davis S, Soboleva A.

Nucleic Acids Res. 2013 Jan;41(Database issue):D991-5. doi: 10.1093/nar/gks1193. Epub 2012 Nov 27.

18.

AAV2 gene therapy readministration in three adults with congenital blindness.

Bennett J, Ashtari M, Wellman J, Marshall KA, Cyckowski LL, Chung DC, McCague S, Pierce EA, Chen Y, Bennicelli JL, Zhu X, Ying GS, Sun J, Wright JF, Auricchio A, Simonelli F, Shindler KS, Mingozzi F, High KA, Maguire AM.

Sci Transl Med. 2012 Feb 8;4(120):120ra15. doi: 10.1126/scitranslmed.3002865.

19.

The human visual cortex responds to gene therapy-mediated recovery of retinal function.

Ashtari M, Cyckowski LL, Monroe JF, Marshall KA, Chung DC, Auricchio A, Simonelli F, Leroy BP, Maguire AM, Shindler KS, Bennett J.

J Clin Invest. 2011 Jun;121(6):2160-8. doi: 10.1172/JCI57377. Epub 2011 May 23. Erratum in: J Clin Invest. 2011 Jul 1;121(7):2945.

20.

NCBI GEO: archive for functional genomics data sets--10 years on.

Barrett T, Troup DB, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH, Sherman PM, Muertter RN, Holko M, Ayanbule O, Yefanov A, Soboleva A.

Nucleic Acids Res. 2011 Jan;39(Database issue):D1005-10. doi: 10.1093/nar/gkq1184. Epub 2010 Nov 21.

21.

Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial.

Maguire AM, High KA, Auricchio A, Wright JF, Pierce EA, Testa F, Mingozzi F, Bennicelli JL, Ying GS, Rossi S, Fulton A, Marshall KA, Banfi S, Chung DC, Morgan JI, Hauck B, Zelenaia O, Zhu X, Raffini L, Coppieters F, De Baere E, Shindler KS, Volpe NJ, Surace EM, Acerra C, Lyubarsky A, Redmond TM, Stone E, Sun J, McDonnell JW, Leroy BP, Simonelli F, Bennett J.

Lancet. 2009 Nov 7;374(9701):1597-605. doi: 10.1016/S0140-6736(09)61836-5. Epub 2009 Oct 23. Erratum in: Lancet. 2010 Jan 2;375(9708):30.

22.

NCBI GEO: archive for high-throughput functional genomic data.

Barrett T, Troup DB, Wilhite SE, Ledoux P, Rudnev D, Evangelista C, Kim IF, Soboleva A, Tomashevsky M, Marshall KA, Phillippy KH, Sherman PM, Muertter RN, Edgar R.

Nucleic Acids Res. 2009 Jan;37(Database issue):D885-90. doi: 10.1093/nar/gkn764. Epub 2008 Oct 21.

23.

Safety and efficacy of gene transfer for Leber's congenital amaurosis.

Maguire AM, Simonelli F, Pierce EA, Pugh EN Jr, Mingozzi F, Bennicelli J, Banfi S, Marshall KA, Testa F, Surace EM, Rossi S, Lyubarsky A, Arruda VR, Konkle B, Stone E, Sun J, Jacobs J, Dell'Osso L, Hertle R, Ma JX, Redmond TM, Zhu X, Hauck B, Zelenaia O, Shindler KS, Maguire MG, Wright JF, Volpe NJ, McDonnell JW, Auricchio A, High KA, Bennett J.

N Engl J Med. 2008 May 22;358(21):2240-8. doi: 10.1056/NEJMoa0802315. Epub 2008 Apr 27.

24.

Contemporary management of neuropathic pain for the primary care physician.

Chen H, Lamer TJ, Rho RH, Marshall KA, Sitzman BT, Ghazi SM, Brewer RP.

Mayo Clin Proc. 2004 Dec;79(12):1533-45. Review.

PMID:
15595338
25.

Effect of overexpression of BCL-2 on cellular oxidative damage, nitric oxide production, antioxidant defenses, and the proteasome.

Lee M, Hyun DH, Marshall KA, Ellerby LM, Bredesen DE, Jenner P, Halliwell B.

Free Radic Biol Med. 2001 Dec 15;31(12):1550-9.

PMID:
11744329
26.

Anchored reference loci in loblolly pine (Pinus taeda L.) for integrating pine genomics.

Brown GR, Kadel EE 3rd, Bassoni DL, Kiehne KL, Temesgen B, van Buijtenen JP, Sewell MM, Marshall KA, Neale DB.

Genetics. 2001 Oct;159(2):799-809.

27.

In vitro selection of RNA aptamers.

Marshall KA, Ellington AD.

Methods Enzymol. 2000;318:193-214. No abstract available.

PMID:
10889989
28.

Training ribozymes to switch.

Marshall KA, Ellington AD.

Nat Struct Biol. 1999 Nov;6(11):992-4.

PMID:
10542083
29.

Molecular parasites that evolve longer genomes.

Marshall KA, Ellington AD.

J Mol Evol. 1999 Nov;49(5):656-63.

PMID:
10552046
30.

The neuronal toxicity of sulfite plus peroxynitrite is enhanced by glutathione depletion: implications for Parkinson's disease.

Marshall KA, Reist M, Jenner P, Halliwell B.

Free Radic Biol Med. 1999 Sep;27(5-6):515-20.

PMID:
10490270
31.

Complication of Bullard laryngoscope: dislodgment of blade-extender resulting in an upper airway foreign body.

Marshall KA.

Anesthesiology. 1998 Dec;89(6):1604-5. No abstract available.

PMID:
9856752
32.

Toxic effects of sulphite in combination with peroxynitrite on neuronal cells.

Reist M, Marshall KA, Jenner P, Halliwell B.

J Neurochem. 1998 Dec;71(6):2431-8.

33.

Upregulation of the anti-apoptotic protein Bcl-2 may be an early event in neurodegeneration: studies on Parkinson's and incidental Lewy body disease.

Marshall KA, Daniel SE, Cairns N, Jenner P, Halliwell B.

Biochem Biophys Res Commun. 1997 Nov 7;240(1):84-7.

PMID:
9367887
34.
35.

Managing cancer pain: basic principles and invasive treatments.

Marshall KA.

Mayo Clin Proc. 1996 May;71(5):472-7. Review.

PMID:
8628027
36.

Evaluation of the antioxidant activity of melatonin in vitro.

Marshall KA, Reiter RJ, Poeggeler B, Aruoma OI, Halliwell B.

Free Radic Biol Med. 1996;21(3):307-15.

PMID:
8855441
38.

Accumulation of HL-60 leukemia cells in G2/M and inhibition of cytokinesis caused by two marine compounds, bistratene A and cycloxazoline.

Watters DJ, Beamish HJ, Marshall KA, Gardiner RA, Seymour GJ, Lavin MF.

Cancer Chemother Pharmacol. 1994;33(5):399-409.

PMID:
8306414
39.

Breast-feeding reduces maternal lower-body fat.

Kramer FM, Stunkard AJ, Marshall KA, McKinney S, Liebschutz J.

J Am Diet Assoc. 1993 Apr;93(4):429-33.

PMID:
8454811
40.

Adrenal suppression and paraspinal corticosteroids.

Marshall KA, Chaplan SR.

Anesth Analg. 1992 May;74(5):773. No abstract available.

PMID:
1567047
41.
42.

Structure-activity relationships of the lissoclinamides: cytotoxic cyclic peptides from the ascidian Lissoclinum patella.

Hawkins CJ, Lavin MF, Marshall KA, van den Brenk AL, Watters DJ.

J Med Chem. 1990 Jun;33(6):1634-8.

PMID:
2342056
43.

Hand infections in the diabetic and the diabetic renal transplant recipient.

Francel TJ, Marshall KA, Savage RC.

Ann Plast Surg. 1990 Apr;24(4):304-9.

PMID:
2353778
44.

Chloroplast and mitochondrial DNA are paternally inherited in Sequoia sempervirens D. Don Endl.

Neale DB, Marshall KA, Sederoff RR.

Proc Natl Acad Sci U S A. 1989 Dec;86(23):9347-9.

45.

Limited weight losses with a gastric balloon.

Kramer FM, Stunkard AJ, Spiegel TA, Deren JJ, Velchik MG, Wadden TA, Marshall KA.

Arch Intern Med. 1989 Feb;149(2):411-3.

PMID:
2916886
46.
47.

Excision of multiple epidermal facial cysts in Gardner's syndrome.

Marshall KA, Kuhlmann TP, Horowitz JH, Silloway KA, Edlich RF.

Am J Surg. 1985 Nov;150(5):615-6.

PMID:
4061744
48.

When a patient commits suicide.

Marshall KA.

Suicide Life Threat Behav. 1980 Spring;10(1):29-40.

PMID:
7361342
49.

Use of the temporalis muscule flap in blanking out orbits.

Holmes AD, Marshall KA.

Plast Reconstr Surg. 1979 Mar;63(3):336-43.

PMID:
368836
50.

Xeroradiography in the diagnosis of facial fractures.

Marshall KA, Sadowsky NL, Sigman D.

Plast Reconstr Surg. 1978 Aug;62(2):207-11.

PMID:
674410

Supplemental Content

Loading ...
Support Center